Additionally, a recent study demonstrated that, in NSCLC, smaller panels are more sensitive than larger ones in detecting alterations in commonly altered genes (e.g., EGFR and BRAF) and therefore represent a more useful tool at disease diagnosis [57]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.